LHC Net Worth 2006-2020 | LHCG
Interactive chart of historical net worth (market cap) for LHC (LHCG) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. LHC net worth as of September 28, 2020 is $6.55B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $6.553B | $2.080B |
| LHC Group Inc. is a provider of in-home healthcare services. The company's service covers healthcare needs for patients and families dealing with illness, injury or chronic conditions. LHC Group Inc., formerly known as LHC Group LLC, is based in Lafayette, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teladoc Health (TDOC) | United States | $17.843B | 0.00 |
| BIOMERIEUX (BMXMF) | France | $17.713B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.670B | 0.00 |
| Avantor (AVTR) | United States | $12.857B | 31.86 |
| PPD (PPD) | United States | $11.992B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.099B | 31.38 |
| NovoCure (NVCR) | Jersey | $10.950B | 902.67 |
| ICON (ICLR) | Ireland | $9.976B | 28.75 |
| Amplifon S.p.A (AMFPF) | Italy | $7.471B | 46.48 |
| PRA Health Sciences (PRAH) | United States | $6.342B | 23.78 |
| Natera (NTRA) | United States | $5.596B | 0.00 |
| GETINGE AB (GNGBY) | Sweden | $5.375B | 25.79 |
| Premier (PINC) | United States | $3.969B | 13.03 |
| Medpace Holdings (MEDP) | United States | $3.892B | 36.15 |
| HealthEquity (HQY) | United States | $3.806B | 36.68 |
| AMN Healthcare Services Inc (AMN) | United States | $2.738B | 17.77 |
| Progyny (PGNY) | United States | $2.427B | 470.50 |
| UDG HEALTHCARE (UDHCF) | Ireland | $2.338B | 0.00 |
| CareDx (CDNA) | United States | $1.696B | 0.00 |
| BioTelemetry (BEAT) | United States | $1.533B | 24.92 |
| So-Young (SY) | China | $1.232B | 150.88 |
| Surgery Partners (SGRY) | United States | $1.005B | 0.00 |
| Apollo Medical Holdings (AMEH) | United States | $0.938B | 28.27 |
| Healthways (TVTY) | United States | $0.681B | 9.17 |
| Establishment Labs Holdings (ESTA) | $0.436B | 0.00 | |
| China Cord Blood (CO) | China | $0.412B | 5.95 |
| Co-Diagnostics (CODX) | United States | $0.399B | 78.89 |
| Constellation Alpha Capital (DMTK) | United States | $0.206B | 0.00 |
| RTI Surgical (SRGA) | United States | $0.152B | 0.00 |
| Imprimis Pharmaceuticals (HROW) | United States | $0.148B | 0.00 |
| XpresSpa (XSPA) | United States | $0.136B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.100B | 0.00 |
| Biocept (BIOC) | United States | $0.058B | 0.00 |
| OpGen (OPGN) | United States | $0.044B | 0.00 |
| Interpace Diagnostics (IDXG) | United States | $0.013B | 0.00 |
| Cancer Genetics (CGIX) | United States | $0.010B | 0.00 |
| New Frontier (NFH) | China | $0.000B | 0.00 |
